Abstract
Sibutramine is a tertiary amine that has been shown to induce dose-dependent weight loss and enhance the effects of a low-calorie diet for up to a year. We did a randomised, double-blind trial to assess the usefulness of sibutramine in maintaining substantial weight loss over 18 months.
Bidragets oversatte titel | The effect of sibutramine for the maintenance of weight loss. A randomized controlled clinical trial |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 163 |
Udgave nummer | 21 |
Sider (fra-til) | 2935-40 |
Antal sider | 6 |
ISSN | 0041-5782 |
Status | Udgivet - 21 maj 2001 |
Emneord
- Adolescent
- Adult
- Aged
- Anti-Obesity Agents
- Cyclobutanes
- Diet, Reducing
- Double-Blind Method
- Female
- Humans
- Lipids
- Male
- Middle Aged
- Patient Selection
- Weight Loss